Experiment 407090

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)EFFECTS DUE TO A COMBINATION OF DRUGSSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE

Compounds isolated

STEARIC ACID

Details

PropertyValue
Pharmacology
COCARCINOGENIC ACTIVITY
Administration routeEXTERNAL
OrganismEmpty organism
CitationVAN DUUREN,BL: GOLDSCHMIDT,BM:. (1976). COCARCINOGENIC AND TUMOR-PROMOTING AGENTS IN TOBACCO CARCINOGENESIS.. 56()
Amount utilized
Compound isolated
DiseaseAPPLICATION 3 TIMES WEEKLY TOGETHER WITH BENZO-(A)-PYRENE)FOR 440 DAYS 25/50 MICE HAD 38 PAPILLOMAS(7 WERE SQUAMOUS CARCINOMAS),THE FIRST APPEARING ON DAY 195
Dose amount4.0 MG
Number1
Qualitative resultEQUIVOCAL
AnimalMOUSE
Per unitANIMAL
Dose expressionCONC USED
GenderFEMALE